glp-1 lawsuit news Ozempic® The next frontier in GLP-1

Zhu P, Herrington WG, Haynes R et al

Novo Nordisk and Eli Lilly, who initially received approval for GLP-1 treatments for diabetes in 2005 and 2010, respectively, are now advancing five new weight-loss drugs in phase 3 trials

The clinical trials showing lean mass reductions were not conducted on people doing three sets of Romanian deadlifts and hitting 1.6 grams of protein per kilogram

Equity Considerations : Efforts must be made to ensure equitable access to these therapies while addressing cost and insurance coverage barriers

Opt for gentle, sulfate-free shampoos and conditioners to prevent stripping natural oils, which can make hair more prone to breakage

Both medications should be taken in conjunction with diet and regular exercise